Nacl Industries Ltd · NSE:NACLIND
Nacl Industries — Q1 FY2022 Earnings Presentation
43 slides from Nacl Industries's earnings presentation, Aug 16, 2021
Slide 1: Cover letter to stock exchanges
A NACL Industries Limited NJ\GARJUNA N ACL Ref: NACL/SE/2021-22 16th August, 2021 1) BSE Limited 2) National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers Exchange Plaza, 5thFloor Dalal Street, Plot No.C/ 1 G Block, Fort, Mumbai, Bandra -Kurla Complex, Bandra (E) Mumbai 400001 Mumbai-400051.
Slide 2: NACL Industries Limited Investor Presentation Q1 FY2022
NACL Industries Limited Investor Presentation | Q1 FY2022
Slide 3: Forward Looking Statement
Forward Looking Statement This presentation contains forward-looking statements, including, but not limited to, the statements and expectations contained in this presentation. Statements herein, other than statements of historical fact, regarding future events or prospects, are forward- looking stat
Slide 4: Content
CONTENT CORPORATE IDENTITY OPERATIONAL HIGHLIGHTS RESULTS SUMMARY PERFORMANCE TRACK RECORD ANNEXURE SHAREHOLDERS INFORMATION
Slide 5: Corporate Identity
CORPORATE IDENTITY
Slide 6: About NACL
ABOUT NACL • Concern • Commitment • Quality • Integrity NACL is an established agrochemical Company in India, founded in 1993. The Company started as an Active Ingredient manufacturer and has built a sizable business in Domestic Retail, B2B and Exports, with many of the customers being large MNCs wi
Slide 7: Quick Facts
QUICK FACTS 12,500 3 1200+ Retailers Manufacturing Employee Units Strength 5 57 30 25+ Million Farmers Branded Geographical Years of ( Customers ) Products Presence Experience Investor Presentation 6
Slide 8: Geographical Reach
GEOGRAPHICAL RESEARCH USA 30 Uzbekistan Countries Iran Lebanon 12,500 Egypt Nepal Taiwan Retailers Thailand Sudan Jordan India Costa Rica 32 Columbia Uganda Yemen Ethiopia Ecuador Tanzania Sri Lanka Revenue from International (%) Zambia 03 Paraguay Myanmar Manufacturing Plants Argentina Australia In
Slide 9: Product Portfolio: Technicals
PRODUCT PORTFOLIO Branded Products Portfolio of NACL includes Insecticides, Herbicides, Fungicides and Plant Growth Regulators TECHNICALS Insecticides Fungicides Herbicides Profenofos Myclobutanil Pretilachlor Lambda-Cyhalothrin Propiconazole Bispyribac Sodium Imidacloprid Tricyclazole Metribuzin Bi
Slide 10: Product Portfolio: Formulations
PRODUCT PORTFOLIO Formulations Plant Growth Insecticides Fungicides Herbicides Regulators & Nagarjuna Index Atonik Nematicides Profex Super Eraze Profex Nagarjuna Result Eraze Plus Gallant EG Cannon Combi Plus Eraze Strong Gallant Gold Fury Sivic Eraze-N Nagarjuna Nipit Dxtar Mass Plus Globus Trust
Slide 11: Operational Highlights
OPERATIONAL HIGHLIGHTS
Slide 12: Operational Highlights for Q1FY22
Operational Highlights for Q1FY22 For the quarter ending June'21, Revenue from operations stood at ₹ 32,468 lakhs, registering a growth of 29% YoY and recorded Profit after tax of ₹ 1 1,431 lakhs registering a growth of 167% YoY 2 Exports business grew over 40% YoY, despite the logistic hurdles acro
Slide 13: Results Summary
ae 7 ai ge rz ; - Ye : - RESULTS SUMMARY
Slide 14: Result Summary – Q1FY22
RESULT SUMMARY – Q1FY22 (In ₹ lakhs) Revenue EBITDA PAT 28.83% 47.52% 166.98% 32,468 25,202 3,154 1,431 2,138 536 Q1FY21 Q1FY22 Q1FY21 Q1FY22 Q1FY21 Q1FY22 Revenue Breakup (₹ in lakhs) Plant Growth Regulators & Insecticides Herbicides Fungicides Nematicides 23% 44% 32% 209% Q1FY22 15,368 6,232 9,842
Slide 15: Revenue Split – Q1FY22
REVENUE SPLIT – Q1FY22 Q1FY22 Q1FY21 Product Category-wise (%) Product Category-wise (%) Formulation Technical Formulation Technical 2% 1% 12% 11% 21% 29% 17% 22% 55% 60% 19% 64% 16% 71% Insecticides Herbicides Fungicides Plant Growth Regulators & Nematicides Insecticides Herbicides Fungicides Plant
Slide 16: Profit and Loss – Q1FY22 (Standalone)
PROFIT AND LOSS – Q1FY22 (Standalone) (₹ in lakhs) Particulars Q1FY22 Q4FY21 Q1FY21 Y-o-Y (%) Revenue from operations 32,468 33,043 25202 29% Other income 315 649 322 Total Income 32,783 33,692 25,524 28% Expenses: (a) Cost of materials consumed 26,424 20,479 18,213 45% (b) Purchase of stock-in-trad
Slide 17: Profit and Loss – Q1FY22 (Consolidated)
PROFIT AND LOSS – Q1FY22 (Consolidated) (₹ in lakhs) Particulars Q1FY22 Q4FY21 Q1FY21 Y-o-Y (%) Revenue from operations 32,468 33,043 25,202 29% Other income 267 584 322 Total Income 32,735 33,627 25,524 28% Expenses: (a) Cost of materials consumed 26,424 20,479 18,213 45% (b) Purchase of stock-in-t
Slide 18: Performance Track Record
PERFORMANCE TRACK RECORD
Slide 19: Historic Quarterly Trend (1/2)
HISTORIC QUARTERLY TREND (1/2) (₹ in lakhs) Revenue from Operations EBITDA and EBITDA Margin 5,00 0 15. 00% 34,417 4,259 33,043 32468 4,00 0 10.78% 12.28% 3,521 9.62% 30,172 8.38% 10. 00% 7.80% 10.45% 3,154 27,663 7.45% 7.36% 2,888 26,475 3,00 0 7.00% 25,202 2,383 23,868 2,138 2,044 5.0 0% 2,00 0 1,
Slide 20: Historic Quarterly Trend (2/2)
HISTORIC QUARTERLY TREND (2/2) (₹ in lakhs) PBT and PBT Margin PAT and PAT Margin 4,00 0 10. 00% 2,50 0 8.0 0% 8.42% 6.65% 1,869 2,921 5.81% 2,00 0 6.0 0% 5.35% 1,714 4.37% 3,00 0 3.40% 2,239 5.0 0% 3.35% 3.15% 1,50 0 5.39% 1431 4.0 0% 2.53% 5.09% 1905 2.11% 2.10% 2,00 0 1.76% 1.80% 1.28% 910 0.72%
Slide 21: Financial Performance (1/2)
FINANCIAL PERFORMANCE (1/2) (₹ in lakhs) Revenue from Operations EBITDA and EBITDA Margin CAGR 10.17% CAGR 12.48% 1,19,137 14,0 00 10.61% 12. 00% 1,01,489 12,0 00 8.37% 7.66% 7.44% 10. 00% 84,606 86,549 10,0 00 12,806 8.0 0% 73,411 8,00 0 4.42% 6.0 0% 6,00 0 7,607 4,00 0 7,113 6,777 4.0 0% 2,00 0 3,
Slide 22: Financial Performance (2/2)
FINANCIAL PERFORMANCE (2/2) (₹ in lakhs) Working Capital Days Net Worth 41,148 154 35,053 134 131 27,865 22,588 23,500 79 82 FY17 FY18 FY19 FY20 FY21 FY17 FY18 FY19 FY20 FY21 ROCE and ROE Debt to Equity (x) 20.68% 0.21 17.57% 0.20 15.84% 13.57% 0.16 12.22% 14.04% 6.27% 4.56% 4.50% 0.10 0.09 -3.01% F
Slide 23: Credit Rating
CREDIT RATING Long Term Bank Facilities Short Term Bank Facilities ₹ 288.56 Crores ₹ 85.00 Crores CARE A; Stable CARE A1 (Single A; Outlook: Stable) (A One) Revised from Revised from CARE A-; Positive CARE A2+ (Single A Minus; Outlook: Positive) (A Two Plus) Investor Presentation 22
Slide 24: Annexure
ANNEXURE
Slide 25: Timeline (1/2)
TIMELINE (1/2) Acquired two Pesticide Commencement of Chemagro Formulation Plants at Monocrotophos International Limited The 3rd Technical The 4th Technical Ethakota in East Godavari (MCP) commercial became Nagarjuna Manufacturing Manufacturing District and a Pesticide production. Agrichem Limited a
Slide 26: Timeline (2/2)
TIMELINE (1/2) Increased focus on branded Renamed as NACL Commission of Zero Liquid Awarded with “Responsible business and crop segment Industries Limited and got Block 7 at Discharge (ZLD) Care’’ logo by Indian Chemical Geographic expansion both listed on NSE. Srikakulam Plant was Council in domest
Slide 27: Board of Directors
BOARD OF DIRECTORS Mrs. K Lakshmi Raju Mr. M Pavan Kumar Mr. Sudhakar Kudva Mr. N Vijayaraghavan Mr. Raghavender Mr. Atul Churiwal Chairperson & Non- Managing Director & Independent Director Non-Executive Director Mateti Investor Nominee Executive Director CEO Independent Director Director Mr. Rajes
Slide 28: Key Management Team
KEY MANAGEMENT TEAM Mr. Amit Taparia Dr. B. Saha Mr. Harish Chandra Mr. G. Jagannadha Rao Mr. S. Mani Prasad Mr. Amit Tandon Senior VP – SCM, Chief Research & Bijlwan Executive VP – Exports Head – Human Potential Vice President - Procurement, IT and Development Officer VP – Operations & and Domestic
Slide 29: NACL's Business Model
NACL’S BUSINESS MODEL Value Creation Process Technical 50+ Branded Products, 47 manufacturing plant NACL stock points and with a production 12,500 retail outlets capacity of 10,000 across India under the metric tons per Company’s direct to retail annum approach Knowledge A state-of- Formulation unit
Slide 30: Business Strategy
BUSINESS STRATEGY Tap new Strengthening Farmer Centric Human Development Focus on geographies and and enhancing product Initiatives to develop efficient spread distribution global development and leadership skills and responsible network collaborations sales approach manufacturing Substantial capaci
Slide 31: NACL – A Unique Investment Case
NACL – A UNIQUE INVESTMENT CASE Capable R&D Robust product Technocrat team with the portfolio that is Long standing Board members state-of-the-art spread business relations and facility center to across insecticides, with Multi-national Senior develop the cost herbicides, agrochemical management eff
Slide 32: Certificates
CERTIFICATES ICC (Indian Chemical Council) has granted permission for use of the Responsible Care Logo, for a period of Three Years. Responsible Care certification is increasingly recognized as a differentiator in the Chemical Industry for doing business in Domestic and International market. The R&D
Slide 33: Certificates: ISO and NABL Accreditations
CERTIFICATES ISO ACCREDITATIONS NABL ACCREDITATIONS ISO 45001:2018 ISO 14001:2015 ISO 9001:2015 R&D Facility Ethakota Unit Srikakulam Unit DSIR Investor Presentation 32
Slide 34: Awards and Accolades
AWARDS AND ACCOLADES Best Company of the Year 2017 Certificate of Appreciation NACL has been awarded “Best Company of the Year 2017” NACL’s Ethakota Unit has bagged the presented by International Brand prestigious SAFETY AWARD for the Consulting Corporation (IBCC), year 2018,2019 & 2020 from the USA
Slide 35: Key External Drivers of the Business
KEY EXTERNAL DRIVERS OF THE BUSINESS Indian Agrochemical Market The agrochemicals market in India is expected to register 8% CAGR to reach US$ 3.7 billion by FY22 and US$ 4.7 billion by FY25. With the government propagating the development of the agricultural sector and with the recent proposals und
Slide 36: Research & Development
RESEARCH & DEVELOPMENT Development of New generation, environment friendly and safe formulations 3 R&D labs at Shadnagar and Srikakulam are DSIR recognized. Quality Control labs in the above locations and Ethakota are NABL accredited. 4 Process development of active ingredients and intermediates 2 R
Slide 37: Production Capacity
PRODUCTION CAPACITY PRODUCTION CAPACITY Ethakota Unit, AP 12,000 KL Liquid Formulation 5,600 MT Powder Formulation 35,475 MT Granule Formulation Technical Grade 10,000 MT * Srikakulam Unit, AP * Under significant expansion Investor Presentation 36
Slide 38: Capacity Expansion Plans
CAPACITY EXPANSION PLANS NACL Multichem Private Limited, Ranasthalam NACL Spec-Chem Limited, Dahej, Gujarat Mandal, Srikakulam CAPACITY CAPACITY NACL Spec-Chem Limited, a wholly owned NACL Multichem Private Limited, a wholly owned 25,000 subsidiary of NACL is planning to setup a greenfield 38,000 su
Slide 39: Development at Dahej Greenfield Project
Development at Dahej Greenfield Project Investor Presentation 38
Slide 40: Sustainability – Environment, Health & Safety
SUSTAINABILITY – ENVIRONMENT, HEALTH & SAFETY Manufacturing Plants, Strong EHS systems, are certified processes, inspection Integrated Efficient and training who Management Systems equipment for enhance awareness related to quality, reduced energy and ensure practices environment, health consumption
Slide 41: Shareholders Information
SHAREHOLDERS INFORMATION
Slide 42: Shareholders Information
SHAREHOLDERS INFORMATION Stock Information (as on 13th August 2021) (As on 30th June 2021) Market Capitalization (₹) 1286.77 Cr Shareholding Pattern (%) Shares Outstanding 19.78 Cr Free Float 257.35 Cr Symbol (BSE) / (NSE) 524709 / NACLIND 33.88% Stock Performance Chart (as on 13th August 2021) 64.1
Slide 43: Thank You
THANK YOU NACL Industries Limited Plot No 12-A, C Block, Lakshmi Towers, NACL Industries Limited Nagarjuna Hills, Punjagutta, Hyderabad - 500082, Telangana, India +91-40 -24405100 info@naclind.com https://naclind.com/ Contact S-ancial Technologies Pvt. Ltd. Nikunj Jain | Bhavya Shah (Investor Relati